All In Biotech

Drug Trial Radar · NCT00658632

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)

A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)

Last checked: Nov 20, 2026Latest source record: May 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,397 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,397

Actual

Start

Feb 2008

Primary completion

Apr 2009

Study completion Sep 2009

Sponsor

Lead sponsor
Eisai Inc.Eisai
Sponsor type
Industry
First posted
Apr 15, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the efficacy and safety of Rabeprazole (RAB) Extended-Release (ER) 50 mg versus Esomeprazole (ESO) 40 mg in subjects with erosive gastroesophageal reflux disease (eGERD).

Conditions

  • Gastroesophageal Reflux Disease (GERD)

Interventions

  • Rabeprazole sodiumDrug

    Rabeprazole ER 50 mg capsule, once daily for 4-8 weeks.

  • EsomeprazoleDrug

    Esomeprazole 40 mg capsule, once daily for 4-8 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Erosive Gastroesophageal Reflux Disease (eGERD) Who Achieved Endoscopically-confirmed Healing by 8 WeeksTime frame: Baseline and Week 8
  2. Percentage of Participants With eGERD Who Achieved Endoscopically-confirmed Healing by 4 WeeksTime frame: Baseline and Week 4

Locations

85 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Huntsville, Alabama

  • Site not named

    Tucson, Arizona

  • Site not named

    Tucson, Arizona

  • Site not named

    Little Rock, Arkansas

  • Site not named

    Sherwood, Arkansas

  • Site not named

    Anaheim, California

  • Site not named

    Chula Vista, California

  • Site not named

    Fullerton, California

  • Site not named

    Irvine, California

  • Site not named

    Laguna Hills, California

  • Site not named

    Mission Hills, California

  • Site not named

    Redwood City, California

  • Site not named

    San Diego, California

  • Site not named

    San Louis Obispo, California

  • Site not named

    West Covina, California

  • Site not named

    Pueblo, Colorado

  • Site not named

    Wheat Ridge, Colorado

  • Site not named

    Bristol, Connecticut

  • Site not named

    Hartford, Connecticut

  • Site not named

    Boynton Beach, Florida

  • Site not named

    Hialeah, Florida

  • Site not named

    Hollywood, Florida

  • Site not named

    Jacksonville, Florida

  • Site not named

    Jupiter, Florida

  • Site not named

    Largo, Florida

  • Site not named

    Lauderdale Lakes, Florida

  • Site not named

    Naples, Florida

  • Site not named

    Orlando, Florida

  • Site not named

    Tampa, Florida

  • Site not named

    Tampa, Florida

  • Site not named

    Tampa, Florida

  • Site not named

    Newnan, Georgia

  • Site not named

    Rockford, Illinois

  • Site not named

    Clive, Iowa

  • Site not named

    Kansas City, Kansas

  • Site not named

    Topeka, Kansas

  • Site not named

    Louisville, Kentucky

  • Site not named

    Louisville, Kentucky

  • Site not named

    Baton Rouge, Louisiana

  • Site not named

    Slidell, Louisiana

Showing 40 of 85 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.